Invivo studies
- Nociceptive Pain
- Neuropathic Pain Models
- Inflammatory Pain
- Target Engagement
- Biomarker Analysis
Xenograft
Oncology Models
Subcutaneous Xenograft Models
- Lung (HCC827, Calu-6, H1975, A549)
- Breast (MDA-MB-231)
- Colon (HT-29, Colo-205, HCT116)
- Prostate (PC3, DU-145)
- Gastric (MKN-45, AGS)
- Pancreatic (PANC-1, MIAPaCa)
- Others (A431, U-87 MG, B16-F10)
Orthotopic Xenograft models
- Breast and Prostate
Metastatic Xenograft models
- Lung and Liver
Syngeneic tumor models
- B16F10
PK-PD modelsScreening Models in Mice and Rats
- Xenograft Tumors
- Western Blot, ELISA, MSD and FACS based PD marker assessment in Tumor tissue
Metabolic Disorder Models and Biomarker for In Vivo Pharmacology
- Diet Induced obesity (DIO)
- Incretin and endocrine secretion - GLP-1, PYY/CCK
Toxicology
- Zebra fish/ Guppi fish, Histopathology and efficacy
- Wound healing efficacy evaluation in diabetic wistar albino rats